Biotech News
Dyne Therapeutics to Participate in Upcoming Investor Conferences
investors.dyne-tx.com2026-05-06 14:47 EST
WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to participate in the